ArticleCureus2026
Impact of Double-J Stent on Patient Outcomes and Healthcare Costs in Saudi Arabia: A Retrospective Cross-Sectional Study From a Tertiary Care Center.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDouble-J (DJ) ureteral stents are commonly used to relieve urinary tract obstruction, yet their placement often leads to pain and other complications that can affect patients' quality of life (QOL). This study evaluated the impact of DJ stents on patient outcomes and healthcare burden in Saudi Arabia.
methodsA retrospective cross-sectional study was conducted at Security Forces Hospital, Riyadh, including 135 patients who underwent ureteral stent placement between January 2021 and January 2024. The primary outcome was stent-related quality of life measured using the Ureteral Stent Symptom Questionnaire (USSQ). Data from medical records and telephone-based USSQ interviews were analyzed using descriptive statistics and logistic regression in IBM SPSS Statistics, version 27 (IBM Corp., Armonk, NY, USA).
resultsWhile a majority of patients reported acceptable post-stent QOL, many experienced pain and work-related difficulties. Pain was the most common complication, followed by sexual and urinary symptoms. The estimated per-patient healthcare cost of stent management ranged from 5,138 to 5,268 Saudi Riyal (SAR; ≈1,370-1,405 USD), reflecting a notable economic burden.
conclusionAlthough DJ stenting remains effective in relieving obstruction, stent-related morbidity, particularly pain and reduced daily functioning, was significantly associated with poorer quality of life and increased healthcare burden. Optimizing perioperative care, patient education, and timely stent removal may help improve outcomes and reduce the overall system burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.